Smartphone Biosensor System with Multi-Testing Unit Based on Localized Surface Plasmon Resonance Integrated with Microfluidics Chip

Abstract

Detecting biomarkers is an efficient method to diagnose and monitor patients’ stages. For more accurate diagnoses, continuously detecting and monitoring multiple biomarkers are needed. To achieve point-of-care testing (POCT) of multiple biomarkers, a smartphone biosensor system with the multi-testing-unit (SBSM) based on localized surface plasmon resonance (LSPR) integrated multi-channel microfluidics was presented. The SBSM could simultaneously record nine sensor units to achieve the detection of multiple biomarkers. Additional 72 sensor units were fabricated for further verification. Well-designed modularized attachments consist of a light source, lenses, a grating, a case, and a smartphone shell. The attachments can be well assembled and attached to a smartphone. The sensitivity of the SBSM was 161.0 nm/RIU, and the limit of detection (LoD) reached 4.2 U/mL for CA125 and 0.87 U/mL for CA15-3 through several clinical serum specimens testing on the SBSM. The testing results indicated that the SBSM was a useful tool for detecting multi-biomarkers. Comparing with the enzyme-linked immunosorbent assays (ELISA) results, the results from the SBSM were correlated and reliable. Meanwhile, the SBSM was convenient to operate without much professional skill. Therefore, the SBSM could become useful equipment for point-of-care testing due to its small size, multi-testing unit, usability, and customizable design.

How Nanophotonic Label-Free Biosensors Can Contribute to Rapid and Massive Diagnostics of Respiratory Virus Infections: COVID-19 Case

“… 131 Additional components such as external light sources, like affordable LEDs or broadband lights, collimators, or polarizers, can be included in an adapted miniaturized design, involving also compatible and suitable customized polymer shell or housing to merge with the cell phone. More examples are appearing trying to combine smartphone technology with plasmonic biosensors, 132 , 133 although the performance is still undermined compared with robust laboratory versions and they have been tested with model biosensing systems or with limited analytical characterization.…”

COVID-19 Biomarkers and Advanced Sensing Technologies for Point-of-Care (POC) Diagnosis

“…A few characteristics of this detection platform include excellent sensitivity levels, minimizing interferences due to electromagnetic disturbances, and ease of use. Their detection capabilities are preferred due to their safe, ease of use, and cost-effective technology [112]. Optical biosensors measure changes in the optical properties of the propagated light when a binding interaction occurs between the immobilized receptor, most times an antibody or antigen with the target analyte.…”

Point-of-Care for Evaluating Antimicrobial Resistance through the Adoption of Functional Materials

“…Plasmonics is an optical technology used in disease monitoring, diagnostics, food safety, and biological imaging applications . At the intersection of analytical chemistry and optics, plasmonic-stemmed modalities can improve the performance of pre-existing platforms by enabling reliable, real-time, susceptible, and label-free detection of analytes while minimizing the need for special equipment. , Over the last decades, surface plasmon resonance (SPR) − and localized surface plasmon resonance (LSPR) , sensors have been created for diagnostic and monitoring applications among many types of label-free technologies.…”